Themes of the
Challenges and opportunities for improvement for ethics committees and regulators, for publishers, for institutions and researchers, and for funders. Methods for measurement and for testing interventions.
Programme
We are pleased to present a diverse range of invited speakers, including Dr Kris Thayer, Director of the Integrated Risk Information Systems Division at the US Environmental Protection Agency; Dr Allison Harbin, freelance writer and editor whose blog describing her PhD experience has resonated with graduate students across disciplines; Sir Jim Smith, Director of Science at the Wellcome Trust, and Dr Jonathan Kimmelman, a bioethicist concerned with the social and policy dimensions of translational research. Further details of these and other speakers are available here.
Our ambition has been to create a faculty of insiders and outsiders, of those immersed every day in the challenges of biomedical research and of others from outside this narrow world, that their perspective may bring new understanding to the problems we face.
The meeting will include an inaugural EQUATOR Doug Altman lecture by Prof Isabelle Boutron, Université Paris Descartes, France. As well as these invited speakers, submitted research (oral presentations and posters), we have created space for less traditional conference formats including so-called focus tracks (structured discussions between conference participants, proposed by anyone attending the conference) and formats encouraging authors to present content that is relevant to the conference themes, however doesn’t fit into the research abstract format („Concepts, Initiatives and Ideas”). Details of these can be found here.
The conference, however, will only be truly successful through the contributions of all participants. We welcome people at every career stage, and from every country. To support this participation, we will support the attendance of junior researchers and those from emerging or developing countries (LDC) through a bursary scheme, provided for the top 10 abstract submissions with first authors who are ECRs, and for the top 10 with first authors from LDC. Please check here for more details.
Please bring your most interesting work, an open mind, and an enthusiasm to engage with your colleagues. For “traditional” research submissions, we are interested in the most relevant, rigorous and contemporary material; and we are particularly interested in work which describes the evaluation or implementation of strategies to reduce research waste.
A detailed programme will be available approx. in Fall.
Keynote and
Plenary Speakers
- Lisa Anne Bero University of Sydney | Sydney, Australia
- Anne-Marie Coriat Wellcome Trust | London, UK
- Lisa Debruine University of Glasgow | Glasgow, Scotland
- Daniele Fanelli London School of Economics and Political Science | London, UK
- Claudia Gerstle* United Airlines | Chicago, USA
- Allison Harbin Post Ph.D. | New York, USA
- Jonathan Kimmelman McGill University | Montreal, Canada
- Frank F. Miedema Utrecht University & UMC Utrecht | Utrecht, The Netherlands
- Ivan Oransky New York University & Retraction Watch | New York, USA
- Vinay Prasad Oregon Health and Science University | Portland, USA
- Jim Smith Wellcome Trust | London, UK
- Kristina Thayer United States Environmental Protection Agency | Washington D.C., USA
*(pending confirmation)
Jonathan Kimmelman | McGill University
Jonathan Kimmelmann
Frank F. Miedema | Utrecht University & UMC Utrecht
Frank F. Miedema
Ivan Oransky | New York University & Retraction Watch
Ivan Oransky
Lisa DeBruin | University of Glasgow
Lisa DeBruin
Jim Smith | Wellcome Trust
Jim Smith
Lisa Anne Bero | The University of Sydney
Lisa Anne Bero
Kristina Thayer | United States Environmental Protection Agency
Kristina Thayer
Daniele Fanelli | London School of Economics
Daniele Fanelli
Certification
ECTS
- for participation in congresses, symposia, conferences and similar events · 0.33 ECTS Credit Points will be credited per full day (approx. 8 hours),
- for half a conference day · 0.15 ECTS Credit Points will be credited.
- for the presentation of one’s own work, for example as a conference contribution · 1 ECTS Credit Point will be credited
The conference programme is usually sufficient proof for posters/presentations.
Berlin Chamber of Physicians
The conference will apply for certification at the Berlin Chamber of Physicians.
A certification of attendance will be sent to all attendees 2 weeks after the conference.
Scientific Programme
Committee
- Ginny Barbour Queensland University of Technology | Brisbane, Australia
- Lex Bouter Vrije Universiteit | Amsterdam, The Netherlands
- Isabelle Boutron Université Paris Descartes | Paris, France
- Ulrich Dirnagl BIH QUEST Center | Berlin, Germany
- Paul Glasziou Bond University | Gold Coast, Australia
- Sabine Kleinert The Lancet | London, UK
- Malcolm Macleod (Chair) University of Edinburgh | Edinburgh, Scotland
- Marcus Munafo University of Bristol | Bristol, UK
- Brian Nosek Center for Open Science & University of Virginia | Charlottesville, USA
- Daniel Strech BIH QUEST Center | Berlin, Germany
Lex Bouter | Vrije Universiteit
Lex Bouter
Ulrich Dirnagl | BIH QUEST Center
Ulrich Dirnagl
Paul Glasziou | Bond University
Paul Glasziou
Malcolm Macleod (Chair) | University of Edinburgh
Malcolm Macleod
Marcus Munafò | University of Bristol
Marcus Munafò
Brian Nosek | Center for Open Science & University of Virginia
Brian Nosek
Daniel Strech | BIH QUEST Center
Daniel Strech
Contact
Host
Charité – Universitätsmedizin Berlin
BIH QUEST Center
Charitéplatz 1
10117 Berlin, Germany
Local Organiser (PCO)
MCI Deutschland GmbH
MCI | Germany – Berlin
Markgrafenstr. 56
10117 Berlin, Germany
T: +49 30 20459220
F: +49 30 2045950
rec2020@mci-group.com
Registration
T: +49 30 20459090
registration.berlin@mci-group.com
Project Management
Amira Hussein
T: +49 30 20459220
rec2020@mci-group.com
Professor Paul Glasziou is Professor of Evidence-Based Medicine at Bond University was a part-time General Practitioner for 20 years. He is currently the Director of the Centre for Research in Evidence-Based Practice at Bond University and previously the Director of the Centre for Evidence-Based Medicine in Oxford from 2003-2010. His key interests include identifying and removing the barriers to using high quality research in everyday clinical practice and more specifically on improving the clinical impact of publications by reducing the more than $85 Billion annual loss from unpublished and unusable research (Chalmers, Glasziou, Lancet 2009).
Brian Nosek is co-Founder and Executive Director of the Center for Open Science (
Prof Virginia (Ginny) Barbour is the Director of the Australasian Open Access Strategy Group, and advisor to the library and the Office of Research Ethics & Integrity at Queensland University of Technology (QUT), Brisbane, Australia. In 2004 she was one of the three founding editors of PLOS Medicine. She was the journal’s first Chief Editor, ultimately becoming PLOS Medicine and Biology Editorial Director. She chaired the Committee on Publication Ethics from 2012-2017. She has a medical degree from Cambridge University, and a DPhil from the University of Oxford. She has participated in many publishing and ethics initiatives, including the DORA International Advisory board and the NHMRC’s Research Quality Steering Committee.
Marcus Munafò is Professor of Biological Psychology at the University of Bristol, and Programme Lead within the MRC Integrative Epidemiology Unit. Together with Angela Attwood and Olivia Maynard, he leads the Tobacco and Alcohol Research Group (
Professor Lex M Bouter, PhD, has a tenured chair in Methodology and Integrity at the Department of Epidemiology and Biostatistics of the Amsterdam University Medical Centers and the Department of Philosophy of the Faculty of Humanities of the Vrije Universiteit. Before taking up the current position he was professor of Epidemiology. He served his university as its rector between 2006 and 2013. He is a member of the Steering Committee of the REWARD (REduce research Waste And Reward Diligence) Alliance and chair of the World Conferences on Research Integrity Foundation. Lex Bouter has supervised 75 PhD students, of whom to date 16 were appointed as professor.
Jim joined Wellcome in December 2016 as Director of Science and is now reviewing how best Wellcome can support science to achieve the best advances in knowledge and health. He also leads a research group at the Francis Crick Institute, where he studies inductive interactions in vertebrate development and applies the principles of developmental biology to stem cell differentiation.
Malcolm Macleod is Professor in Neurology and Translational Neuroscience at the Centre for Clinical Brain Sciences, University of Edinburgh. After training in Internal Medicine his PhD concerned the neuroprotective actions of FK506 and post-doctoral work in the Seckl lab defined a neuroprotective role for increased expression of the mineralocorticoid receptor. During a pivotal sabbatical year with Donnan at the National Stroke Research Institute in Melbourne he began an involvement with stroke clinical trials, and it was in an effort to identify suitable drugs for such clinical trials that he began to develop techniques to allow the systematic review and meta-analysis of data from animal studies.
Martin Reinhart is assistant professor in the Sociology of Science at Humboldt-Universität zu Berlin and the German Center for Higher Education Research and Science Studies. He is the director of the Robert K. Merton Center for Science Studies and his work focuses on peer review and evaluation in science, on scientific misconduct, and on translational biomedical research.
Lisa DeBruine is a professor of psychology at the Univeristy of Glasgow. Her meta-science interests include team science (especially the Psychological Science Accelerator), open documentation, data simulation, web-based tools for data collection and stimulus generation, and teaching computational reproducibility. Her substantive research is on the social perception of faces and kinship. Her projects and tutorials are available at 
Dr. Stephanie Müller-Ohlraun is the administrative head of the QUEST Center for Transforming Biomedical Research at the Berlin Institute of Health, Berlin, Germany.
At the Charité – Universitätsmedizin Berlin Ulrich Dirnagl is Professor for Clinical Neurosciences and serves as Director of the Department of Experimental Neurology. Since 2017 he is also the founding director of the QUEST Center for Transforming Biomedical Research at the Berlin Institute of Health. QUEST aims at overcoming the roadblocks in translational medicine by increasing the value and impact of biomedical research through maximizing the quality, reproducibility, generalizability, and validity of research.
Sarah McCann is a postdoctoral research fellow at the BIH QUEST Center in Berlin. She trained in preclinical neuroprotection research utilising in vivo stroke models. During this time, she became aware of the issues surrounding the poor translation of results from animal experiments to clinical benefit. Her research has since focussed on using preclinical systematic review and meta-analysis to investigate the factors contributing to these issues, and ways to help improve the predictive potential of animal research in stroke and in biomedicine more broadly.
Bob Siegerink is an epidemiologist with lab training, who works as Principal Investigator at the Center for Stroke Research, Charité – Universitätsmedizin Berlin. Together with his group he works on several projects aimed to unravel the causes and consequences of stroke and understand the potential of new treatments concepts. He provides methodological support to researchers from other research groups of the CSB, both clinical and preclinical. Besides his work in vascular neurology, Bob has a strong interest in research methodology, quality of research, causal inference and scientific integrity, which resulted in several scientific projects, courses and collaborations.
Jonathan Kimmelman, PhD, is James McGill Professor of Biomedical Ethics at McGill University, and directs the Biomedical Ethics Unit as well as his own research group, STREAM (Studies in Translation, Ethics and Medicine). Kimmelman’s research centers on ethical, policy, and scientific dimensions of clinical development. In addition to his book, Gene Transfer and the Ethics of First-in-Human Experiments (Cambridge Press, 2010), major publications have appeared in Science, JAMA, BMJ, and Hastings Center Report. Kimmelman received the Maud Menten New Investigator Prize (2006), a CIHR New Investigator Award (2008), a Humboldt Bessel Award (2014), and was elected a Hastings Center Fellow (2018). He has sat on various advisory bodies within the U.S. NHLBI and NIAID, served for four tours of duty on U.S. National Academies of Medicine committees, and chaired the International Society of Stem Cell Research Guidelines for Stem Cell Research and Clinical Translation revision task force 2015-16. His research has been covered in major media outlets, including NPR’s All Things Considered, STATNews, and Nature. Kimmelman is deputy editor at Clinical Trials, and serves as an associate editor at PLoS Biology.
Ivan Oransky, MD, is co-founder of Retraction Watch, vice president of editorial at Medscape, and distinguished writer in residence at New York University’s Arthur Carter Journalism Institute. He also serves as president of the Association of Health Care Journalists. Ivan previously was global editorial director of MedPage Today, executive editor of Reuters Health, and held editorial positions at Scientific American and The Scientist. A 2012 TEDMED speaker, he is the recipient of the 2015 John P. McGovern Medal for excellence in biomedical communication from the American Medical Writers Association, and in 2017 was awarded an honorary doctorate in civil laws from The University of the South (Sewanee).
Frank Miedema, PhD, professor of Immunology, is Vice Rector for Research and chair of the Utrecht University Open Science Program. He studied biochemistry in Groningen and obtained a PhD from the University of Amsterdam. After a career in biomedical (HIV/AIDS) research in Amsterdam, from January 2009 to March 2019 he was dean and vice chairman of the Executive Board at the University Medical Center Utrecht. He is one of the initiators of Science in Transition (2013) who argued that science and in particular the academic incentive and reward system is in need of fundamental reform to increase quality and impact. Next to Science for Science, the impact on society must be valued more and societal stakeholders should be involved more in the production of knowledge.